| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.52e-06 | 11 | 43 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 4.42e-05 | 32 | 43 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.01e-04 | 42 | 43 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 3.48e-04 | 13 | 43 | 2 | GO:0008046 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.92e-05 | 31 | 40 | 3 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 4.24e-05 | 35 | 40 | 3 | GO:0099188 | |
| GeneOntologyBiologicalProcess | cell junction organization | 8.19e-05 | 974 | 40 | 9 | GO:0034330 | |
| GeneOntologyBiologicalProcess | cellular response to type III interferon | 1.99e-04 | 11 | 40 | 2 | GO:0071358 | |
| GeneOntologyBiologicalProcess | type III interferon-mediated signaling pathway | 1.99e-04 | 11 | 40 | 2 | GO:0038196 | |
| GeneOntologyBiologicalProcess | axon development | 2.09e-04 | 642 | 40 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | response to type III interferon | 2.82e-04 | 13 | 40 | 2 | GO:0034342 | |
| GeneOntologyBiologicalProcess | neuron development | POTEE RPGRIP1 SEMA4F ROBO2 POTEI HMCN2 CAMSAP2 MAP4K4 POTEF USP21 | 3.71e-04 | 1463 | 40 | 10 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | 6.48e-04 | 1285 | 40 | 9 | GO:0031175 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.22e-04 | 566 | 40 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 7.95e-04 | 802 | 40 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 8.99e-04 | 819 | 40 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 9.04e-04 | 23 | 40 | 2 | GO:0032012 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 9.45e-04 | 826 | 40 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 9.85e-04 | 24 | 40 | 2 | GO:0032011 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 9.85e-04 | 24 | 40 | 2 | GO:0031290 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.98e-06 | 45 | 42 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 3.59e-05 | 32 | 42 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 3.59e-05 | 32 | 42 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.76e-05 | 94 | 42 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | interleukin-28 receptor complex | 3.93e-05 | 5 | 42 | 2 | GO:0032002 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.59e-05 | 104 | 42 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.72e-05 | 109 | 42 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | actin filament | 3.14e-03 | 146 | 42 | 3 | GO:0005884 | |
| Domain | Actin_CS | 5.00e-06 | 16 | 40 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 6.06e-06 | 17 | 40 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 7.26e-06 | 18 | 40 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 8.61e-06 | 19 | 40 | 3 | PS01132 | |
| Domain | Actin | 3.92e-05 | 31 | 40 | 3 | IPR004000 | |
| Domain | Actin | 3.92e-05 | 31 | 40 | 3 | PF00022 | |
| Domain | ACTIN | 3.92e-05 | 31 | 40 | 3 | SM00268 | |
| Domain | Ank_2 | 1.13e-03 | 215 | 40 | 4 | PF12796 | |
| Domain | Ank | 1.40e-03 | 228 | 40 | 4 | PF00023 | |
| Domain | - | 1.91e-03 | 248 | 40 | 4 | 1.25.40.20 | |
| Domain | ANK | 1.99e-03 | 251 | 40 | 4 | SM00248 | |
| Domain | ANK_REPEAT | 2.05e-03 | 253 | 40 | 4 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.08e-03 | 254 | 40 | 4 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.08e-03 | 254 | 40 | 4 | PS50297 | |
| Domain | Ankyrin_rpt | 2.33e-03 | 262 | 40 | 4 | IPR002110 | |
| Domain | Ig_I-set | 7.77e-03 | 190 | 40 | 3 | IPR013098 | |
| Domain | I-set | 7.77e-03 | 190 | 40 | 3 | PF07679 | |
| Pathway | WP_TYPE_III_INTERFERON_SIGNALING | 1.46e-04 | 10 | 26 | 2 | M39464 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 7.93e-07 | 15 | 43 | 3 | 16824795 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.49e-06 | 2 | 43 | 2 | 19669888 | |
| Pubmed | Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. | 4.48e-06 | 3 | 43 | 2 | 22891284 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 4.48e-06 | 3 | 43 | 2 | 17101985 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 19798076 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 16618774 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 31462571 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 35523172 | ||
| Pubmed | IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. | 1.49e-05 | 5 | 43 | 2 | 12483210 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 18787692 | ||
| Pubmed | IFN-lambda determines the intestinal epithelial antiviral host defense. | 1.49e-05 | 5 | 43 | 2 | 21518880 | |
| Pubmed | Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero. | 1.49e-05 | 5 | 43 | 2 | 28910635 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 12469119 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 28514692 | ||
| Pubmed | Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. | 2.23e-05 | 6 | 43 | 2 | 32527928 | |
| Pubmed | An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. | 2.23e-05 | 6 | 43 | 2 | 18250457 | |
| Pubmed | A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis. | 4.16e-05 | 8 | 43 | 2 | 31130511 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 16364570 | ||
| Pubmed | 5.56e-05 | 1442 | 43 | 9 | 35575683 | ||
| Pubmed | IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus. | 8.15e-05 | 11 | 43 | 2 | 37703370 | |
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 26006013 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.35e-04 | 211 | 43 | 4 | 24097068 | |
| Pubmed | Characterization of human colon cancer antigens recognized by autologous antibodies. | 1.77e-04 | 16 | 43 | 2 | 9610721 | |
| Pubmed | 2.32e-04 | 96 | 43 | 3 | 23580065 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.22e-04 | 265 | 43 | 4 | 19240061 | |
| Pubmed | 4.05e-04 | 24 | 43 | 2 | 11668390 | ||
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 5.14e-04 | 27 | 43 | 2 | 30936491 | |
| Pubmed | Disruption of parental-specific expression of imprinted genes in uniparental fetuses. | 5.93e-04 | 29 | 43 | 2 | 16987518 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 6.64e-04 | 569 | 43 | 5 | 30639242 | |
| Pubmed | 8.39e-04 | 149 | 43 | 3 | 22664934 | ||
| Pubmed | 1.09e-03 | 163 | 43 | 3 | 24316575 | ||
| Cytoband | 2q21.1 | 2.28e-05 | 58 | 43 | 3 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 3.91e-04 | 151 | 43 | 3 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 3.52e-03 | 325 | 43 | 3 | chr9q34 | |
| Cytoband | 9q34.3 | 4.48e-03 | 106 | 43 | 2 | 9q34.3 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.17e-06 | 13 | 30 | 3 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 6.53e-04 | 242 | 30 | 4 | 403 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.36e-03 | 161 | 30 | 3 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.72e-03 | 206 | 30 | 3 | 682 | |
| Coexpression | GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN | 1.78e-05 | 198 | 43 | 5 | M3317 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.17e-06 | 433 | 43 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.83e-05 | 616 | 43 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.61e-05 | 462 | 43 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.66e-05 | 463 | 43 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.72e-05 | 197 | 43 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.58e-05 | 508 | 43 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.47e-05 | 529 | 43 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.58e-05 | 530 | 43 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.15e-04 | 383 | 43 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.23e-04 | 978 | 43 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.66e-04 | 410 | 43 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.87e-04 | 419 | 43 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.90e-04 | 420 | 43 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.65e-04 | 447 | 43 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.99e-04 | 457 | 43 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.56e-04 | 196 | 43 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 6.60e-04 | 974 | 43 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 6.69e-04 | 976 | 43 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 146 | 43 | 4 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.26e-05 | 148 | 43 | 4 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.66e-05 | 159 | 43 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.83e-05 | 182 | 43 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.10e-05 | 63 | 43 | 3 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.27e-05 | 189 | 43 | 4 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.27e-05 | 189 | 43 | 4 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.93e-05 | 198 | 43 | 4 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.03e-03 | 914 | 38 | 6 | EFO_0004532 | |
| Disease | retinal nerve fibre layer thickness measurement | 1.41e-03 | 43 | 38 | 2 | EFO_0600004 | |
| Disease | hepatocyte growth factor measurement | 1.48e-03 | 44 | 38 | 2 | EFO_0006903 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.55e-03 | 447 | 38 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | retinal layer thickness measurement | 2.73e-03 | 60 | 38 | 2 | EFO_0600002 | |
| Disease | C-reactive protein measurement | 4.14e-03 | 1206 | 38 | 6 | EFO_0004458 | |
| Disease | erosive tooth wear measurement | 6.02e-03 | 90 | 38 | 2 | EFO_0009331 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPSQQREIRGPAVPR | 346 | Q96Q91 | |
| QPLPRRNVPVGITEG | 871 | Q8TDY4 | |
| AAPVTQPTRRVFPRG | 81 | Q07092 | |
| RGVSPEGRRPPVVVN | 481 | C9J069 | |
| LSPNQGRVAVVIRPP | 841 | Q5JWR5 | |
| RRRGAPAAPQQQSEP | 171 | Q8WXF8 | |
| GRAPRGRVANQIPPE | 26 | Q9BZG8 | |
| QVQRRGSLPPRQVPR | 166 | Q86UR1 | |
| IQPPQPTGGRRRRVV | 356 | Q02930 | |
| APRAVFPSIVGRPRQ | 726 | A5A3E0 | |
| QRPAEPQVPVRTTSR | 616 | O95819 | |
| APAVIRQAPPVIRQA | 461 | Q9UJ55 | |
| GVRPTPRVRAPATQQ | 301 | Q8IU57 | |
| RVRVQAPPNIVGPRG | 3586 | Q8NDA2 | |
| TPEQRRSRQGNPVAP | 286 | Q10471 | |
| RGPGRARAAPVPVVV | 1301 | Q96Q04 | |
| PRPVVLQGMQVRRVP | 726 | Q9H6A9 | |
| VPQPREGRPRAQAQL | 296 | Q50LG9 | |
| CVEPGPARPQVRRVN | 166 | Q1L5Z9 | |
| SVPVPPVRVRDAQGA | 101 | Q96IR7 | |
| APRAVFPSIVGRPRQ | 726 | Q6S8J3 | |
| VREGPQLQDAVPQRP | 61 | Q8N8I6 | |
| IQPQPTAGPRTRGRL | 141 | Q8IZJ0 | |
| PGPPSRRVENVVLRA | 11 | A2IDD5 | |
| QRTRQVLGPSRPGVP | 951 | Q6UXX5 | |
| TNRGRITPVPRSQEP | 11 | Q9H9L4 | |
| PQVSPRQRVQRSQPV | 101 | Q13322 | |
| RAQGQRQSPRGVTPP | 61 | Q8N4W6 | |
| EVPVVRPLQPRAARG | 51 | Q7Z3Z3 | |
| FVQPRVVRPQGAEPV | 341 | Q08AD1 | |
| VGPASPRRAQPRVQV | 131 | Q96KN7 | |
| QGPRPVLGRESVQVP | 11 | Q9Y365 | |
| NRGLPVVDNDVPQPR | 366 | O95754 | |
| RTVVPQRLCPRNPPQ | 6 | Q5HYW2 | |
| QRRFVRPILPVGPAQ | 906 | Q8NDX1 | |
| APRAVFPSIVGRPRQ | 726 | P0CG38 | |
| VARPTVSSGPVPRRQ | 386 | Q68D10 | |
| TNVATGAPPRRQRVP | 36 | P49842 | |
| RTREPPVNIQPRVGS | 11 | Q9UK80 | |
| EPLQQGRGPVPVRRQ | 6 | Q9H2B4 | |
| RAPPQFVVRPRDQIV | 311 | Q9HCK4 | |
| IPRNTGTPQRVLRPV | 6 | Q8N9G6 | |
| PTVGARRRPSVPQEQ | 156 | O14771 | |
| TLRQSFVPVRPGPRQ | 751 | P22735 | |
| QRVRVALPQGPRAPG | 36 | Q658N2 |